ArticleEndocrinology, diabetes & metabolism2025
Estimated Glucose Disposal Rate: A Potential Determinant for Microvascular and Macrovascular Complications in Type 2 Diabetes.
Article in Endocrinology, diabetes & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict diabetic kidney disease development and progression: evidence from two nationwide cohorts and a biopsy-proven clinical cohort.Cardiovascular diabetology · 2026Article
- A practical tool for risk stratification: eGDR as a predictor of incident diabetic kidney disease.BMC endocrine disorders · 2026Article
- Comparing the diagnostic performance of metabolic indices in metabolic dysfunction-associated fatty liver disease patients: a retrospective cross-sectional study.European journal of medical research · 2026Article
- Coronary angiography-derived microcirculatory resistance predicts adverse cardiovascular events in elderly with unstable angina post-percutaneous coronary intervention.Frontiers in aging · 2026Article
- Article
- Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study.Cardiovascular diabetology · 2025Article
- Oxidative balance score and mortality: mediating role of insulin resistance across age strata in the NHANES cohort.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study investigates the association between estimated glucose disposal rate (eGDR), a measurement of insulin resistance, and microvascular and macrovascular complications in patients with type 2 diabetes (T2D).
methodsThis cross-sectional study enrolled 7471 patients with T2D from 2010 to 2023. The eGDR was calculated using waist circumference, HbA1C levels, and hypertension status. Logistic regression analysis and restricted cubic splines were utilised to examine the relationship between eGDR and vascular complications, including nephropathy, retinopathy, and coronary artery disease (CAD). The robustness of the results and between-group interactions were examined by sensitivity and subgroup analysis. Furthermore, receiver operating characteristic (ROC) curve analysis was employed to assess the discriminatory value of the adjusted model for T2D vascular complications.
resultsAmong participants, 56.5% were female, with a mean age of 57.04 ± 11.05 years and a median of 8 years of diabetes duration. In the final adjusted model, each unit increase in the standard deviation of eGDR was significantly associated with a 23.6%, 24.8% and 29.6% decrease in the odds of nephropathy, retinopathy, and CAD, respectively. There was a significant association between higher eGDR quartiles compared to Q1 for all complications (p < 0.05). The Q4 group had the lowest adjusted odds ratios (ORs) compared to the Q1 group for all complications; the OR of Q4 was 0.549 for nephropathy, 0.360 for retinopathy, and 0.396 for CAD (p < 0.001). The restricted cubic spline for nephropathy followed a negative nonlinear association with eGDR, whereas for retinopathy and CAD, it followed a negative linear pattern. The effect of eGDR was consistent among different subgroups. The ROC curve analysis of the adjusted model showed good discriminatory power for all complications.
conclusionIn patients with type 2 diabetes, a higher eGDR was significantly associated with a lower risk of microvascular and macrovascular complications, regardless of well-known confounders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.